CVE-2026-47065: ZDRES-232 · resolveProxyClass Not Overridden - acceptMatchers Filter Bypass via
Affects mina2Source GCVE Database
Not known to be exploited · CVSS 9.8 Critical.
Data as of 9 Nov 2026, 14:18 UTC
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 3 Jun 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 9 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
Ubuntu 26.10mina2pkg:deb/ubuntu/mina2?arch=source&distro=stonkingOther threats | Affected
| Fixed in– |
Ubuntu 25.10mina2pkg:deb/ubuntu/mina2?arch=source&distro=questingOther threats | Affected
| Fixed in– |
Ubuntu Pro 24.04 LTSmina2pkg:deb/ubuntu/mina2?arch=source&distro=esm-apps/nobleOther threats | Affected
| Fixed in– |
Ubuntu Pro 22.04 LTSmina2pkg:deb/ubuntu/mina2?arch=source&distro=esm-apps/jammyOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
The vendor has fully addressed these issues. Users should apply the official fixes or upgrade to versions where these vulnerabilities are resolved. No additional mitigation steps are indicated beyond applying the vendor's patches.
Description
CVE-2026-47065 is a critical vulnerability in the mina2 product involving Java deserialization. It arises because the resolveProxyClass method is not overridden, allowing a proxy class to bypass acceptMatchers filtering. Additionally, deserializing allow-listed classes triggers their static initializers, which may have side effects. Both issues have been fully addressed by the vendor.